Tuesday 21 July 2026

Bio-Tech

ACG and AGA Invest in Oshi Health to Boost Hybrid Digestive Health Care Adoption
14th June, 2023

ACG and AGA Invest in Oshi Health to Boost Hybrid Digestive Health Care Adoption

Oshi Health has announced strategic investments by the American C...

Enochian BioSciences' Cancer Platform Advances for Human Trials After FDA Review
09th June, 2023

Enochian BioSciences' Cancer Platform Advances for Human Trials After FDA Review

Enochian BioSciences Inc. announces that it remains confident in submitting...

FITT-IIT Delhi introduces SPARK Programme for early-stage entrepreneurs
08th June, 2023

FITT-IIT Delhi introduces SPARK Programme for early-stage entrepreneurs

FITT-IIT Delhi, the technology transfer office of the Indian Institute...

Bitterroot Bio Raises $145M in Series A to Revolutionize Cardio-Immunology Medicines
08th June, 2023

Bitterroot Bio Raises $145M in Series A to Revolutionize Cardio-Immunology Medicines

Bitterroot Bio, a biotechnology company focused on developing novel immunot...

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia
07th June, 2023

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

BetaLife wins top prize with its potential to provide regenerative medicine...

Acepodia Raises $100M in Series D Funding to Drive Advancements
07th June, 2023

Acepodia Raises $100M in Series D Funding to Drive Advancements

Acepodia, a clinical stage biotechnology company developing first-in-class ...

aVaxziPen Revolutionizes Vaccine Delivery for Enhanced Accessibility and Distribution
06th June, 2023

aVaxziPen Revolutionizes Vaccine Delivery for Enhanced Accessibility and Distribution

aVaxziPen Ltd, a biotech company developing a novel needle-free vaccin...

AccuStem Sciences and University Hospitals Collaborate on Groundbreaking Research
06th June, 2023

AccuStem Sciences and University Hospitals Collaborate on Groundbreaking Research

AccuStem Sciences, Inc., a clinical stage diagnostics company dedicated to ...

Omniscient's MRI-Enhanced Brain Analysis Receives FDA Clearance
05th June, 2023

Omniscient's MRI-Enhanced Brain Analysis Receives FDA Clearance

Omniscient, the world leader in using AI to decode the human brain, today a...

Treace Medical Concepts Acquires Patient-Specific Instrumentation Technology for Foot and Ankle Surgeries
02nd June, 2023

Treace Medical Concepts Acquires Patient-Specific Instrumentation Technology for Foot and Ankle Surgeries

Treace Medical Concepts, Inc., a medical technology company driving a funda...

Elicio Therapeutics Successfully Merges with Angion Biomedica
02nd June, 2023

Elicio Therapeutics Successfully Merges with Angion Biomedica

Elicio Therapeutics, a clinical-stage biotechnology company developing a pi...

AtomVie Global Radiopharma Secures $90M for Facility Buildout
02nd June, 2023

AtomVie Global Radiopharma Secures $90M for Facility Buildout

AtomVie Global Radiopharma Inc., a global-leading CDMO for the GMP manufact...

Telesis Bio Secures Financing of $28.0 Million
01st June, 2023

Telesis Bio Secures Financing of $28.0 Million

Telesis Bio Inc., a leader in molecular biology automation solutions for mu...

Nykode Therapeutics and Roche Collaborate to Evaluate VB10.16 and anti-PD-L1 Combination in Advanced Cervical Cancer Trial
01st June, 2023

Nykode Therapeutics and Roche Collaborate to Evaluate VB10.16 and anti-PD-L1 Combination in Advanced Cervical Cancer Trial

Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated t...

Palette Life Sciences Launches Barrigel Center of Excellence Program Designations
31st May, 2023

Palette Life Sciences Launches Barrigel Center of Excellence Program Designations

Palette Life Sciences, a fully-integrated global life sciences company dedi...

Larkspur Biosciences to Present Breakthrough Innovations at the 2023 BIO International Convention
31st May, 2023

Larkspur Biosciences to Present Breakthrough Innovations at the 2023 BIO International Convention

Larkspur Biosciences is building the next precision immunotherapies to outs...

Trethera Secures $2M NCI Grant for Biomarker Advancement in Phase 1 Trial
31st May, 2023

Trethera Secures $2M NCI Grant for Biomarker Advancement in Phase 1 Trial

Trethera Corporation, a clinical stage biopharmaceutical company committed ...

Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial
30th May, 2023

Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial

Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical ...